Medical Advocates for Social Justice

Kaletra Library Service 
 Conference Abstracts and Posters

  Index of  Kaletra Abstracts and Posters from 
 
  1st International AIDS Society Conference
  on HIV Pathogenesis and Treatment. 
 
  Buenos Aires, Argentina 
 

  July 08- 11, 2001

CONFERENCE POSTER
Comparison of the Emergence of Genotypic Resistance over 60 Weeks of Therapy
with Lopinavir/ritonavir (Kaletra) or Nelfinavir plus d4T/3TC.
Kempf D, Bernstein B, King M, et al.
Poster   Abstract

CONFERENCE POSTER
Factors Affecting Long-Term Virologic Suppression in Phase II Studies of
Lopinavir/ritonavir  (LPV/r) in ARV-Naive or PI-Experienced Patients.
King M, Brun S, Marsh T, et al.
Poster   Abstract

CONFERENCE POSTER
Kaletra (ABT-378/ritonavir) in HIV-Infected Children at 72 Weeks.
Cahn P, Renz C, Saez-Lorens X, et al.
Poster     Abstract

CONFERENCE POSTER
Lopinavir/ritonavir (Kaletra) in Antiretroviral Naïve HIV+ Patients: Week 144
Follow-Up(M97-720).
White, Jr. AC, Brun S, King M, et al. .
Poster   Abstract

CONFERENCE POSTER
Kaletra vs. Nelfinavir in Antiretroviral-Naive Subjects:  Week 60 Comparison in a
Phase III, Blinded, Randomized Clinical Trial.
Ruane P, Mendonca J, Timerman A, et al.
Poster    Abstract 

CONFERENCE POSTER
Safety of Kaletra Data from Phase II and Phase III Clinical Trials
(M98-863; M97-720; M97-765; M97-957)
Bernstein B, King M, Brun S,  et al.
Poster     Abstract